Abstract
The main aim of treating hyperbilirubinemia is to prevent kernicterus and/or neurodevelopmental impairment. Recommendations for treatment are based primarily on the total serum bilirubin (TSB) levels but also as a function of gestational age, birth weight, bilirubin/albumin ratios, and risk factors that increase the risk of bilirubin neurotoxicity. Setting thresholds for intervention in the premature neonate is more challenging than in term babies. Phototherapy is effective in lowering the circulating bilirubin or preventing it from rising further; its primary purpose is to prevent the need for an exchange transfusion. Phototherapy uses visible light energy to change the shape and structure of bilirubin, converting it to molecules that can be excreted even when normal conjugation is deficient. Exchange transfusion remains an important if infrequently required intervention. It is recommended in any infant who is jaundiced and manifests signs of intermediate to advanced stages of acute bilirubin encephalopathy even if the TSB is falling. Pharmacologic agents used in the management of hyperbilirubinemia can accelerate the normal metabolic pathways for bilirubin clearance, inhibit the enterohepatic circulation of bilirubin, and interfere with bilirubin formation by blocking the degradation of heme or inhibiting hemolysis. Currently, the only drug in clinical use is intravenous immunoglobulin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ackerman BD, Dyer GY, Taylor PM (1971) Decline in serum bilirubin concentration coincident with clinical onset of kernicterus. Pediatrics 48:647–650
Ahlfors CE (1994) Criteria for exchange transfusion in jaundiced newborns. Pediatrics 93:488–494
American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia (2004) Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114:297–316
American Association of Blood Banks Technical Manual Committee (2002) Perinatal issues in transfusion practice. In: Brecher M (ed) Technical manual. American Association of Blood Banks, Bethesda, pp 497–515
Amin SB, Ahlfors CE, Orlando MS et al (2001) Bilirubin and serial auditory brainstem responses in premature infants. Pediatrics 107:664–670
Arnold C, Tyson JE, Cuadrado ME et al (2015) Cycled phototherapy: a safer effective treatment for small premature infants. EPAS 1582.605
Aycicek A, Erel O (2007) Total oxidant/antioxidant status in jaundiced newborns before and after phototherapy. J Pediatr (Rio J) 83:319–322
Bender GJ, Cashore WJ, Oh W (2007) Ontogeny of bilirubin-binding capacity and the effect of clinical status in premature infants born at less than 1300 grams. Pediatrics 120:1067–1073
Benders MJNL, van Bel F, van de Bor M (1999) Haemodynamic consequences of phototherapy in term infants. Eur J Pediatr 158:323–328
Bratlid D, Nakstad B, Hansen TW (2011) National guidelines for treatment of jaundice in the newborn. Acta Paediatr 100:499–505
Brown AK, Kim MH, Wu PYK et al (1985) Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 75:393–400
Cashore WJ (1980) Free bilirubin concentrations and bilirubin-binding affinity in term and preterm infants. J Pediatr 96:521–527
Cashore WJ, Oh W (1982) Unbound bilirubin and kernicterus in low birthweight infants. Pediatrics 69:481–485
Cashore WJ, Oh W, Brodersen R (1983) Reserve albumin and bilirubin toxicity index in infant serum. Acta Paediatr Scand 72:415–419
Cnattingius S, Zack MM, Ekbom A et al (1995) Prenatal and neonatal risk factors for childhood lymphatic leukemia. J Natl Cancer Inst 87:908–914
Cremer RJ, Perryman PW, Richards DH (1958) Influence of light on the hyperbilirubinemia of infants. Lancet 1:1094–1097
Csoma Z, Hencz P, Orvos H et al (2007) Neonatal blue-light phototherapy could increase the risk of dysplastic nevus development. Pediatrics 119:1036–1037
Dagoglu T, Ovali F, Samanci N et al (1995) High-dose intravenous immunoglobulin therapy for haemolytic disease. J Internat Med Res 23:264–271
Dahlquist G, Kallen B (2003) Indications that phototherapy is a risk factor for insulin-dependent diabetes. Diabetes Care 26:247–248
Daood MJ, McDonagh AF, Watchko JF (2009) Calculated free bilirubin levels and neurotoxicity. J Perinatol 29:S14–S19
Djokomuljanto S, Quah BS, Surini Y et al (2006) Efficacy of phototherapy for neonatal jaundice is increased by the use of low-cost white reflecting curtains. Arch Dis Child Fetal Neonatal Ed 91:F439–F442
Dollberg S, Atherton HD, Hoath SB (1995) Effect of different phototherapy lights on incubator characteristics and dynamics under three modes of servocontrol. Am J Perinatol 12:55–60
Donneborg ML, Knudsen KB, Ebbesen F (2010) Effect of infants’ position on serum bilirubin level during conventional phototherapy. Acta Paediatr 99:1131–1134
Ebbesen F, Brodersen R (1982) Risk of bilirubin acid precipitation in preterm infants with respiratory distress syndrome: Considerations of blood/brain bilirubin transfer equilibrium. Early Hum Dev 6:341–355
Ebbesen F, Nyboe J (1983) Postnatal changes in the ability of plasma albumin to bind bilirubin. Acta Paediatr Scand 72:665–670
Esbjorner E (1991) Albumin binding properties in relation to bilirubin and albumin concentrations during the first week of life. Acta Paediatr Scand 80:400–405
Figueras-Aloy J, Rodriguez-Miguelez JM, Iriondo-Sanz M et al (2010) Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease. Pediatrics 125:139–144
Funato M, Tamai H, Shimada S, Nakamura H (1994) Vigintiphobia, unbound bilirubin, and auditory brainstem responses. Pediatrics 93:50–53
Gottstein R, Cooke R (2003) Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatol Ed 88:F6–F10
Govaert P, Lequin M, Swarte R et al (2003) Changes in globus pallidus with (pre) term kernicterus. Pediatrics 112:1256–1263
Haddock JH, Nadler HL (1970) Bilirubin toxicity in human cultivated fibroblasts and its modification by light treatment. Proc Soc Exp Biol Med 134:45–48
Hammerman C, Vreman HJ, Kaplan M et al (1996a) Intravenous immune globulin in neonatal immune hemolytic disease: does it reduce hemolysis? Acat Paediatr 85:1351–1353
Hammerman C, Kaplan M, Vreman HJ et al (1996b) Intravenous immune globulin in neonatal ABO isoimmunization: Factors associated with clinical efficacy. Biol Neonate 170:69–74
Hansen TWR (1997) Acute management of extreme neonatal jaundice – the potential benefits of intensified phototherapy and interruption of enterohepatic bilirubin circulation. Acta Paediatr 86:843–846
Hansen TWR, Nietsch L, Norman E et al (2009) Reversibility of acute intermediate phase bilirubin encephalopathy. Acta Paediatr 98:1689–1694
Harris MC, Bernbaum JC, Polin JR et al (2001) Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics 107:1075–1080
Hegyi T, Graff M, Zapanta V et al (1986) Transcutaneous bilirubinometry. III. Dermal bilirubin kinetics under green and blue light phototherapy. Am J Dis Child 140:994–997
Hintz SR, Stevenson DK, Wong R et al (2011) Is phototherapy exposure associated with better or worse outcomes in 501- to 1000-g-birth-weight infants? Acta Paediatr 100:960–965
Hulzebos CV, Dijk PH, van Imhoff DE et al (2014) The bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: a randomized controlled trial – the BARTrial. PLoS One 9, e99466
Ip S, Glicken S, Kulig J et al (2003) Management of neonatal hyperbilirubinemia. AHRQ Publication, Rockville
Ip S, Chung M, Kulig J et al (2004) An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 114:e130–e153
Jackson JC (1997) Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics 99, e7
Jährig K, Jährig D, Meisel P (1982) Dependence of the efficiency of phototherapy on plasma bilirubin concentration. Acta Paediatr Scand 71:293–299
Kaplan M, Kaplan E, Hammerman C et al (2006) Post-phototherapy neonatal bilirubin rebound: a potential cause of significant hyperbilirubinaemia. Arch Dis Child 91:31–34
Kappas A (2004) A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. Pediatrics 113:119–123
Kappas A, Drummond GS, Munson DP, Marshall JR (2001) Sn-mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah’s Witness newborns as an alternative to exchange transfusion. Pediatrics 108:1374–1377
Kara S, Ulu-ozkan H, Yilmaz Y et al (2013) Necrotizing enterocolitis in a newborn following intravenous immunoglobulin treatment for haemolytic disease. J Coll Physicians Surg Pak 23:598–600
Keenan WJ, Novak KK, Sutherland JM et al (1985) Morbidity and mortality associated with exchange transfusion. Pediatrics (Suppl) 75:417–421
Kopelman AE, Brown RS, Odell GB (1972) The “bronze” baby syndrome: A complication of phototherapy. J Pediatr 81:466–472
Krishnan L, Pathare A (2011) Necrotizing enterocolitis in a term neonate following intravenous immunoglobin therapy. Indian J Pediatr 78:743–744
Krishnan L, Pathare A (2012) Author’s Reply. Correspondence in regard to necrotizing enterocolitis in a term neonate following intravenous immunoglobulin therapy. Indian J Pediatr 79:1677
Lai YC, Yew YW 2015 Neonatal blue light phototherapy and melanocytic nevus count in children: a systemic review and meta-analysis of observational studies. Ped Dermatology https://doi.org/10.1111/pde.12730. [Epub ahead of print]
Lamola AA, Eisinger J, Blumberg WE et al (1979) Fluorometric study of the partition of bilirubin among blood components: basis for rapidmicorassays of bilirubin and bilirubin binding capacity in whole blood. Anal Biochem 100:25–42
Lau SP, Fung KP (1984) Serum bilirubin kinetics in intermittent phototherapy of physiological jaundice. Arch Dis Child 59:892–894
Lightner DA, McDonagh AF (1984) Molecular mechanisms of phototherapy for neonatal jaundice. Acc Chem Res 17:417–424
Lipsitz PJ, Gartner LM, Bryla DA (1985) Neonatal and infant mortality in relationship to phototherapy. Pediatrics 75(Suppl):422–441
Louis D, More K, Oberoi S et al (2014) Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis. Arch Dis Child Fetal Neonatal 99:F1–F7
Maayan-Metzger A, Yosipovitch G, Hadad E et al (2001) Transepidermal water loss and skin hydration in preterm infants during phototherapy. Am J Perinatol 18:393–396
Maisels MJ (1996) Why use homeopathic doses of phototherapy? Pediatrics 98:283–287
Maisels MJ (2001) Phototherapy – traditional and nontraditional. J Perinatol 21:S93–S97
Maisels MJ, Kring E (2002) Rebound in serum bilirubin level following intensive phototherapy. Arch Pediatr Adolesc Med 156:669–672
Maisels MJ, Kring EA (2006a) Does intensive phototherapy produce hemolysis in newborns of 35 or more weeks gestation? J Perinatol 26:498–500
Maisels MJ, Kring E (2006b) The contribution of hemolysis to early jaundice in normal newborns. Pediatrics 118:276–279
Maisels MJ, McDonagh AF (2008) Phototherapy for neonatal jaundice. N Engl J Med 358:920–928
Maisels MJ, Watchko JF (2003) Treatment of jaundice in low birthweight infants. Arch Dis Child Fetal Neonatol Ed 88:F459–F463
Maisels MJ, Kring EA, DeRidder J (2007) Randomized controlled trial of light-emitting diode phototherapy. J Perinatol 27:565–567
Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK (2012) An approach to the management of hyperbilirubinemiain the preterm infant less than 35 weeks of gestation. J Perinatol 32:660–664
Mallon E, Wojnarowska F, Hope P, Elder G (1995) Neonatal bullous eruption as a result of transient porphyrinemia in a premature infant with hemolytic disease of the newborn. J Am Acad Dermatol 33:333–336
Martinez JC, Maisels MJ, Otheguy L et al (1993) Hyperbilirubinemia in the breastfed newborn: a controlled trial of four interventions. Pediatrics 91:470–473
Maurer HM, Kirkpatrick BV, McWilliams NB et al (1985) Phototherapy for hyperbilirubinemia of hemolytic disease of the newborn. Pediatrics (Suppl) 75:407–412
McDonagh AF (1990) Is bilirubin good for you? Clin Perinatol 17:359–369
McDonagh AF, Maisels MJ (2006) Bilirubin unbound: deja vu all over again? Pediatrics 117:523–525
Messner KH, Maisels MJ, Leure-DuPree AE (1978) Phototoxicity to the newborn primate retina. Invest Ophthalmol Vis Sci 17:178182
Moll M, Goelz R, Naegele T, Wilke M, Poets CF (2011) Are recommended phototherapy thresholds safe enough for extremely low birth weight (ELBW) infants? A report on 2 ELBW infants with kernicterus despite only moderate hyperbilirubinemia. Neonatology 99:90–94
Morris BH, Oh W, Tyson JE et al (2008) Aggressive vs. conservative phototherapy for infants with extremely low birth weight. New Engl J Med 359:1885–1896
Mreihil K, McDonagh AF, Nakstad B et al (2010) Early isomerization of bilirubin in phototherapy of neonatal jaundice. Pediatr Res 67:656–659
Mreihil K, Madsen P, Nakstad B et al (2015) Early formation of bilirubin isomers during phototherapy for neonatal jaundice: effects of single vs. double flourescent lamps vs. photodiodes. Pediatr Res 78:56–62
Nakamura H, Yonetani M, Uetani Y et al (1992) Determination of serum unbound bilirubin for prediction of kernicterus in low birth weight infants. Acta Paediatr Jpn 54:642–647
National Institute for Health and Clinical Excellence (2010) Neonatal jaundice. www.nice.org.uk/CG98
Navarro M, Negre S, Matoses ML et al (2009) Necrotizing enterocolitis following the use of intravenous immunoglobulin for haemolytic disease of the newborn. Acta Paediatr 98:1214–1217
Newman TB, Maisels MJ (1990) Does hyperbilirubinemia damage the brain of healthy full-term infants? Clin Perinatol 17:331–358
Newman TB, Liljestrand P, Jeremy RJ et al (2006) Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 354:1889–1900
Newman TB, Kuzniewicz MW, Liljestrand P et al (2009) Numbers needed to treat with phototherapy according to American academy of pediatrics guidelines. Pediatrics 123:1352–1359
Oh W, Tyson JE, Fanaroff AA et al (2003) Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics 112:773–779
Oh W, Stevenson DK, Tyson JE et al (2010) Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants. Acta Paediatr 99:673–678
Paller AS, Eramo LR, Farrell EE et al (1997) Purpuric phototherapy-induced eruption in transfused neonates: relation to transient porphyrinemia. Pediatrics 100:360–364
Patra K, Storfer-Isser A, Siner B (2004) Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr 144:626–631
Procianoy RS, Silveira RC, Fonseca LT et al (2010) The influence of phototherapy on serum cytokine concentrations in newborn infants. Am J Perinatol 27:375–379
Rennie JM, Sehgal A, De A et al (2009) Range of UK practice regarding thresholds for phototherapy and exchange transfusion in neonatal hyperbilirubinaemia. Arch Dis Child Fetal Neonatol Ed 94:F323–F327
Robertson L, Harrild K (2010) Maternal and neonatal risk factors for childhood type 1 diabetes: a matched case–control study. BMC Public Health 10:281
Rogerson AG, Grossman ER, Gruber HS et al (1986) 14 years of experience with home phototherapy. Clin Pediatr 25:296–299
Roman E, Ansell P, Bull D (1997) Leukaemia and non-Hodgkin’s lymphoma in children and young adults: are prenatal and neonatal factors important determinants of disease? Brit J Cancer 76:406–415
Rubaltelli FF, Jori G, Reddi E (1983) Bronze baby syndrome: A new porphyrin-related disorder. Pediatr Res 17:327–330
Rubaltelli FF, Guerrini P, Reddi E, Jori G (1989) Tin-protoporphyrin in the management of children with Crigler-Najjar disease. Pediatrics 84:728–731
Rübo J, Albrecht K, Lasch P et al (1992) High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr 121:93–97
Santos MC, Sa CA, Gomes SC, Camacho LA et al (2013) High-dose intravenous immunoglobulin therapy for hyperbilirubinemia due to Rh hemolytic disease: a randomized clinical trial. Transfusion 53:777–782
Scheidt PC, Graubard BI, Nelson KB et al (1991) Intelligence at six years in relation to neonatal bilirubin level: follow-up of the National Institute of Child Health and Human Development Clinical Trial of Phototherapy. Pediatrics 87:797–805
Schulz S, Wong RJ, Vreman HJ et al (2012) Metalloporphyrins – an update. Front Pharmacol 3:68
Sedlak TW, Snyder SH (2004) Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 113:17761782
Seidman DS, Moise J, Ergaz Z et al (2003) A prospective randomized controlled study of phototherapy using blue and blue-green light-emitting devices, and conventional halogen-quartz phototherapy. J Perinatol 23:123–127
Shinwell ES, Sciaky Y, Karplus M (2002) Effect of position changing on bilirubin levels during phototherapy. J Perinatol 22:226–229
Silberberg DH, Johnson L, Schutta H et al (1970) Effects of photodegradation products of bilirubin on myelinating cerebellum cultures. J Pediatr 77:613–618
Sims ME (2011) Legal briefs: Kernicterus still preventable. NeoReviews 12:e727–e730
Sisson TR, Whalen LE, Telel A (1958) A comparison of effects of whole blood and sedimented erythrocytes in exchange transfusion. Pediatrics 21:81–89
Slater L, Brewer MF (1984) Home versus hospital phototherapy for term infants with hyperbilirubinemia: a comparative study. Pediatrics 73:515–519
Slusher TM, Vreman HJ, Olusanya BO et al (2014) Safety and efficacy of filtered sunlight in treatment of jaundice in African neonates. Pediatrics 133:e1568–e1574
Slusher TM, Olusanya BO, Vreman HJ et al (2015) A randomized trial of phototherapy with filtered sunlight in African neonates. New Engl J Med 373:1115–1124
Smits-Wintjens VEHJ, Walther FJ et al (2011) Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial. Pediatrics 127:680–686
Sproul A, Smith L (1964) Bilirubin equilibration during exchange transfusion in hemolytic disease of the newborn. J Pediatr 65:12–26
Strauss KA, Robinson DL, Vreman HJ et al (2006) Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease. Eur J Pediatr 165:306–319
Sugama S, Soeda A, Eto Y (2001) Magnetic resonance imaging in three children with kernicterus. Pediatr Neurol 25:328–331
Tan KL (1982) The pattern of bilirubin response to phototherapy for neonatal hyperbilirubinemia. Pediatr Res 16:670–674
Tatli MM, Minnet C, Kocyigit A et al (2008) Phototherapy increases DNA damage in lymphocytes of hyperbilirubinemic neonates. Mutat Res 654:93–95
Tonz O, Vogt J, Filippini L et al (1975) Severe light dermatosis following phototherapy in a newborn infant with congenital erythropoietic uroporphyria. Helv Paediatr Acta 30:47–56
Tyson JE, Pedroza C, Langer J et al (2012) Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns? J Perinatol 32:677–684
Valaes T (1963) Bilirubin distribution and dynamics of bilirubin removal by exchange transfusion. Acta Paediatr 52(suppl 149):1–115
Valaes T, Petmezaki S, Henschke C et al (1994) Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. Pediatrics 93:1–11
Vandborg PK, Hansen BM, Greisen G et al (2012) Dose–response relationship of phototherapy for hyperbilirubinemia. Pediatrics 130:e352–e357
Vogl TP, Hegyi T, Hiatt IM et al (1978) Intermittent phototherapy in the treatment of jaundice in the premature infant. J Pediatr 92:627–630
Voto LS, Sexer H, Ferreiro G et al (1995) Neonatal adminstration of high-dose intravenous immunoglobulin and rhesus hemolytic disease. J Perinat Med 23:443–451
Vreman HJ, Wong RJ, Stevenson DK (2004) Phototherapy: current methods and future directions. Semin Perinatol 28:326–333
Watchko JF (2000) Exchange transfusion in the management of neonatal hyperbilirubinemia. In: Maisels MJ, Watchko JF (eds) Neonatal Jaundice. Harwood Academic Publishers, London, pp 169–176
Watchko JF (2014) Recent advances in the management of neonatal jaundice. Res Rep Neonatol 4:183–193
Watchko JF (2016) Bilirubin-induced neurotoxicity in the preterm neonate. Clin Perinatol 43:297–311
Watchko JF, Maisels MJ (2014) The enigma of low bilirubin kernicterus in premature infants:why does it still occur, and is it preventable? Semin Perinatol 38:397–406
Watchko JF, Tiribelli C (2013) Bilirubin-induced neurologic damage – mechanisms and management approaches. N Engl J Med 369:2021–2030
Wennberg RP, Ahlfors CE, Bhutani V et al (2006) Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 117:474–485
Yamauchi Y, Casa N, Yamanouchi I (1989) Is it necessary to change the babies’ position during phototherapy? Early Hum Dev 20:221–227
Yetman RJ, Parks DK, Huseby V et al (1998) Rebound bilirubin levels in infants receiving phototherapy. J Pediatr 133:705–707
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this entry
Cite this entry
Watchko, J.F., Maisels, M.J. (2018). Treatment of Hyperbilirubinemia in Newborns. In: Buonocore, G., Bracci, R., Weindling, M. (eds) Neonatology. Springer, Cham. https://doi.org/10.1007/978-3-319-29489-6_223
Download citation
DOI: https://doi.org/10.1007/978-3-319-29489-6_223
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29487-2
Online ISBN: 978-3-319-29489-6
eBook Packages: MedicineReference Module Medicine